Transmembrane signalling systems in the brain of patients with Parkinson's disease. (Q48316986)

10 February 2018

review article

1 reference

title

Transmembrane signalling systems in the brain of patients with Parkinson's disease. (English)

1 reference

10 February 2018

main subject

transmembrane protein

0 references

1 reference

Nishino N

1

1 reference

10 February 2018

Kitamura N

series ordinal

2

1 reference

10 February 2018

Hashimoto T

series ordinal

3

1 reference

10 February 2018

Tanaka C

series ordinal

4

1 reference

10 February 2018

publication date

1 April 1993

1 reference

10 February 2018

Reviews in the Neurosciences

published in

1 reference

10 February 2018

volume

4

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

page(s)

213-222

1 reference

10 February 2018

Positron emission tomography suggests that the rate of progression of idiopathic parkinsonism is slow

cites work

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Dopamine D2 Receptor Imaging with SPECT: Studies in Different Neuropsychiatric Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Dopamine D-1 receptor and cyclic AMP-dependent phosphorylation in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Initial experience with SPECT examinations using [123I]IBZM as a D2-dopamine receptor antagonist in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Aminergic systems in Alzheimer's disease and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Coupling of D1 dopamine receptors to the guanine nucleotide binding protein Gs is deficient in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Regional distribution of mu, delta and kappa opioid receptors in human brains from controls and parkinsonian subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Selective alterations of high affinity [3H]forskolin binding sites in Alzheimer's disease: a quantitative autoradiographic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Cloning and expression of a widely distributed (type IV) adenylyl cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Dementia in idiopathic Parkinson's disease. A neuropathological study of 32 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Dopamine D2 receptor density remains constant in treated Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

The loss of beta II-protein kinase C in the striatum from patients with Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Ca2+/calmodulin-dependent protein kinase II immunoreactivity in Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Inositol 1,4,5-trisphosphate binding sites in the brain: regional distribution, characterization, and alterations in brains of patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Receptor basis for dopaminergic supersensitivity in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Dopamine receptor gene expression by enkephalin neurons in rat forebrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Distribution of high affinity sodium-independent [3H]gamma-aminobutyric acid [3H]GABA binding in the human brain: alterations in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Expression of striatal D1 dopamine receptors coupled to inositol phosphate production and Ca2+ mobilization in Xenopus oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Dopamine stimulates [3H]phorbol 12,13-dibutyrate binding in cultured striatal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Distribution of D2 dopamine receptor mRNA in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Localization of the mRNA for the dopamine D2 receptor in the rat brain by in situ hybridization histochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Visualization of a dopamine D1 receptor mRNA in human and rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Dopamine-stimulated adenylate cyclase activity in the human brain: Changes in Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

DARPP-32 and phosphatase inhibitor-1, two structurally related inhibitors of protein phosphatase-1, are both present in striatonigral neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Increased abundance of alternatively spliced forms of D2 dopamine receptor mRNA after denervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Phorbol ester binding sites in human brain: characterization, regional distribution, age-correlation, and alterations in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

The molecular heterogeneity of protein kinase C and its implications for cellular regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Functional sensitization of striatal dopamine D1 receptors in the 6-hydroxydopamine-lesioned rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

[3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Binding of [3H]SCH 23390 to D-1 receptors in the putamen of control and parkinsonian subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Neurotransmitter receptor alterations in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

GABA receptor binding in the parkinsonian brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Tracing of dopamine receptors in hemiparkinsonism with positron emission tomography (PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

G protein diversity: a distinct class of alpha subunits is present in vertebrates and invertebrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

The role of environmental toxins in the etiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Parkinson's disease: nigral receptor changes support peptidergic role in nigrostriatal modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Mechanisms of signal transduction at the dopamine D2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

D1 and D2 dopamine receptor mRNA in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Progress in understanding the pathophysiology of treatment-related fluctuations in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

Postmortem cerebral cortex Gs alpha-subunit levels are elevated in bipolar affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.1993.4.2.213

10.1515/REVNEURO.1993.4.2.213

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

7952388

1 reference

10 February 2018